All articles tagged with #scientific misconduct
Dana-Farber Cancer Institute agreed to pay $15 million to settle allegations of scientific research fraud involving falsified data and images in publications supported by NIH grants, with misconduct spanning from 2014 to 2024, and the institute cooperated with investigations.
An ethics journal article about whistleblowing in Ethiopia was found to contain at least 19 fabricated references, many generated by AI tools like ChatGPT, raising concerns about the reliability of scientific publications and the need for better verification methods.
The article summarizes recent developments in scientific publishing, including NEJM launching a new public health report rival, a former NIH official's paper receiving an expression of concern, and a study revealing that 1 in 5 chemists have intentionally added errors during peer review, highlighting ongoing issues of misconduct and integrity in research.
An analysis reveals that AI tools like ChatGPT and Gemini are being used to mass-produce low-quality, redundant scientific papers, particularly in biomedical research, which can evade traditional plagiarism checks and flood the literature with synthetic studies, raising concerns about research integrity and the exploitation of open data sets.
A study highlights the rapid growth of research fraud driven by paper mills, brokers, and predatory publishers, outpacing corrective measures like retractions, and calls for global systemic changes to combat this issue effectively.
The article summarizes recent developments in scientific publishing, including the retraction of the 'arsenic life' paper after 15 years, numerous COVID-19 paper retractions, and ongoing issues with misconduct, political interference, and peer review challenges across various journals and research fields.
Robert F Kennedy Jr's health report contains multiple citations to studies that do not exist or are misrepresented, raising concerns about its scientific credibility and the integrity of its findings, amidst broader criticisms of medical publishing and vaccine skepticism.
A French chemist at CNRS has been banned from research for two years due to repeated breaches of research integrity, including fabricating data and manipulating images in over 20 studies, leading to multiple paper retractions and calls for serious corrective actions.
Physicist Ranga Dias has been terminated from the University of Rochester following a formal investigation that concluded he engaged in research misconduct related to his controversial claims of high-temperature superconductivity. Dias' papers, which initially reported breakthroughs in superconductivity at high temperatures, were retracted due to data reliability concerns. Despite Dias' denial of wrongdoing and a dismissed lawsuit claiming bias in the investigation, the university's decision was upheld by the Board of Trustees.
Physicist Ranga Dias defends his discredited research on superconducting materials, claiming he has been unfairly targeted and harassed. Last year, Dias claimed to have created a room-temperature superconductor, but his work has since been widely discredited. Despite the initial excitement over the potential breakthrough, his fellow scientists now accuse him of embarrassing the field.
Sholto David, a Ph.D. in cellular and molecular biology, has gained attention for his expertise in identifying errors and manipulated data in scientific papers, including those from the Dana-Farber Cancer Institute. He believes that the frequency of such errors points to a larger problem within the scientific community and is dedicated to ensuring research accuracy, despite facing criticism and skepticism.
The Dana-Farber Cancer Institute is retracting six papers and correcting 31 others authored by four senior researchers following allegations of data manipulation. The corrections come after claims of misconduct against DFCI President and CEO Laurie H. Glimcher ’72, Executive Vice President and COO William C. Hahn ’87, Senior Vice President for Experimental Medicine Irene M. Ghobrial, and Harvard Medical School professor Kenneth C. Anderson. The institute's research integrity officer stated that they are committed to a culture of accountability and integrity and are examining every inquiry about research integrity fully.
Dana-Farber Cancer Institute is facing allegations of data manipulation in research papers authored by four of its top scientists, including CEO Laurie Glimcher and COO William Hahn. An investigation has been ongoing for over a year, with potential retractions and corrections being considered for several papers. The institute's research integrity officer confirmed that the allegations are credible and warrant further examination, while emphasizing that the presence of image discrepancies does not necessarily indicate misconduct. The institute is committed to a thorough review of the original data and taking appropriate corrective actions.
The effectiveness of antidepressant drugs has long been a topic of debate, with recent revelations of scientific misconduct and fraud in the STAR*D study, which claimed a 67% remission rate for patients with major depressive disorder. The reanalysis of the study revealed that the actual remission rate was only 35%, leading to concerns about the harm caused by inflated results. This has prompted a reevaluation of standard antidepressant treatments and a call for psychiatry to address the significant differences in remission rates, potentially marking a setback for the field.
Former Stanford University President Marc Tessier-Lavigne retracted a 2009 science paper on Alzheimer's disease, marking his fourth retraction in four months due to manipulated data. The retraction follows an investigation that found flaws in his research, leading to his resignation in July. The investigation also revealed lapses in oversight of his labs and failure to correct mistakes in published papers.